US7893101B2
(en)
*
|
2002-03-20 |
2011-02-22 |
Celgene Corporation |
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7135575B2
(en)
*
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
US7521447B2
(en)
*
|
2003-03-03 |
2009-04-21 |
Array Biopharma Inc. |
P38 inhibitors and methods of use thereof
|
US8273347B2
(en)
*
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
CA2536633A1
(en)
*
|
2003-09-10 |
2005-03-24 |
Icagen, Inc. |
Fused ring heterocycles as potassium channel modulators
|
EP1678167A1
(de)
*
|
2003-10-17 |
2006-07-12 |
Incyte Corporation |
Substituierte cyclische hydroxamate als inhibitoren von matrixmetalloproteinasen
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
PL1706385T3
(pl)
|
2003-12-23 |
2011-03-31 |
Astex Therapeutics Ltd |
Pochodne pirazolu jako modulatory kinazy białkowej
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
KR20060114022A
(ko)
*
|
2004-02-27 |
2006-11-03 |
에프. 호프만-라 로슈 아게 |
인다졸 유도체 및 그들을 함유하는 약학 조성물
|
MXPA06009462A
(es)
*
|
2004-02-27 |
2007-03-15 |
Hoffmann La Roche |
Derivados pirazolo heteroaril fusionados.
|
CA2557575A1
(en)
*
|
2004-02-27 |
2005-09-15 |
F. Hoffmann-La Roche Ag |
Fused derivatives of pyrazole
|
ES2475207T3
(es)
|
2004-07-15 |
2014-07-10 |
Tetralogic Pharmaceuticals Corporation |
Compuestos de unión a IAP
|
AP2326A
(en)
*
|
2004-08-12 |
2011-11-24 |
Pfizer |
Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors.
|
EP1647549A1
(de)
*
|
2004-10-14 |
2006-04-19 |
Laboratoire Theramex |
Indazole, Benzisoxazole und Benzisothiazole mit oestrogenen Eigenschaften
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
AU2006216450C1
(en)
|
2005-02-25 |
2013-01-10 |
Medivir Ab |
Dimeric IAP inhibitors
|
MX2007011720A
(es)
*
|
2005-03-22 |
2007-11-20 |
Innate Pharma |
Nueva clase de activadores de celulas t gamma-delta y usos de los mismos.
|
US8362075B2
(en)
*
|
2005-05-17 |
2013-01-29 |
Merck Sharp & Dohme Corp. |
Cyclohexyl sulphones for treatment of cancer
|
MX2007014502A
(es)
|
2005-05-26 |
2008-02-07 |
Metabasis Therapeutics Inc |
Tiromimeticos para el tratamiento de enfermedades del higado graso.
|
JP2008546751A
(ja)
*
|
2005-06-22 |
2008-12-25 |
アステックス・セラピューティクス・リミテッド |
医薬組成物
|
JP5345842B2
(ja)
*
|
2005-06-23 |
2013-11-20 |
アステックス・セラピューティクス・リミテッド |
プロテインキナーゼモジュレーターとしてのピラゾール誘導体を含む医薬組み合わせ
|
ITRM20050344A1
(it)
*
|
2005-06-30 |
2007-01-01 |
Luca Maria De |
Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
AU2006279810B2
(en)
|
2005-08-11 |
2011-10-27 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
BRPI0615442A2
(pt)
*
|
2005-08-25 |
2011-05-17 |
Hoffmann La Roche |
inibidores de p38 map cinase e métodos para uso dos mesmos
|
MX2008002590A
(es)
*
|
2005-08-25 |
2008-03-18 |
Hoffmann La Roche |
Inhibidores de la p38-map-cinasa y metodos para el uso de los mismos.
|
KR101390094B1
(ko)
*
|
2005-09-14 |
2014-04-28 |
산텐 세이야꾸 가부시키가이샤 |
글루코코르티코이드 수용체 결합 활성을 갖는 신규1,2-디히드로퀴놀린 유도체
|
EP1934219A1
(de)
|
2005-09-16 |
2008-06-25 |
Ranbaxy Laboratories Limited |
Substituierte pyrazolo-[3,4-b]-pyridine als phosphodiesterase-inhibitoren
|
WO2007031977A2
(en)
*
|
2005-09-16 |
2007-03-22 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors
|
ES2383090T3
(es)
*
|
2005-10-12 |
2012-06-18 |
Vertex Pharmaceuticals, Inc. |
Derivados de bifenilo como moduladores de los canales iónicos dependientes de voltaje
|
US7939528B2
(en)
*
|
2005-10-13 |
2011-05-10 |
Glaxosmithkline Llc |
Heterocycle compounds
|
PL1971601T3
(pl)
|
2005-11-15 |
2010-03-31 |
Array Biopharma Inc |
Pochodne N4-fenylo-chinazolino-4-aminy i związki pokrewne jako inhibitory receptorowych kinaz tyrozynowych ErbB typu I do leczenia chorób cechujących się nadmierną proliferacją komórek
|
UA94921C2
(en)
*
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
BRPI0621027A2
(pt)
*
|
2006-01-13 |
2011-11-29 |
Pharmacyclics Inc |
composto, composição farmacêutica
|
DK1981851T3
(da)
*
|
2006-01-31 |
2012-03-19 |
Array Biopharma Inc |
Kinaseinhibitorer og fremgangsmåder til anvendelse deraf
|
US8541406B2
(en)
*
|
2006-02-07 |
2013-09-24 |
Nv Remynd |
Thiadiazole derivatives for the treatment of neurodegenerative diseases
|
CA2810839A1
(en)
|
2006-05-04 |
2007-11-15 |
Boehringer Ingelheim International Gmbh |
A polymorphic form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(r)-amino-piperidin-1-yl)-xanthine
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
EP1852108A1
(de)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Zusammensetzungen von DPP-IV-Inhibitoren
|
WO2008005651A2
(en)
*
|
2006-06-08 |
2008-01-10 |
Decode Chemistry, Inc. |
Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
|
US7727978B2
(en)
*
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US20090298811A1
(en)
*
|
2006-09-12 |
2009-12-03 |
Pfizer Inc |
Benzimidazolone derivatives
|
MX2009003160A
(es)
|
2006-09-25 |
2009-04-06 |
Ptc Therapeutics Inc |
Formas cristalinas del acido 3-[5-(2-fluorofenil)-[1,2,4]oxadiazol -3-il]-benzoico.
|
WO2008059866A1
(fr)
*
|
2006-11-14 |
2008-05-22 |
Santen Pharmaceutical Co., Ltd. |
Nouveau dérivé 1,2-dihydroquinoline comprenant un groupe alkyle inférieur à substitution phénylamino et un groupe phényle dans lequel est introduit un ester en tant que substituants
|
TW200831085A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
JP5662682B2
(ja)
*
|
2007-01-18 |
2015-02-04 |
エヴォルヴァ エスアー |
Pparモジュレータとして有用な置換1,3−ジオキサン
|
DE102007009494A1
(de)
*
|
2007-02-27 |
2008-08-28 |
Bayer Healthcare Ag |
Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
|
WO2008112164A2
(en)
|
2007-03-08 |
2008-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
US8030344B2
(en)
*
|
2007-03-13 |
2011-10-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
AU2008231787A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Abbott Gmbh & Co. Kg |
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
US7981917B2
(en)
*
|
2007-03-26 |
2011-07-19 |
University Of Southern California |
Methods and compositions for including apoptosis by stimulating ER stress
|
EP3766493B1
(de)
*
|
2007-04-27 |
2023-08-23 |
CyDex Pharmaceuticals, Inc. |
Methode zur stabilisierung von clopidogrel unter verwendung von sulfoalkylethercyclodextrin
|
EP2011786A1
(de)
*
|
2007-07-05 |
2009-01-07 |
Laboratorios del Dr. Esteve S.A. |
Indanamin-Derivate, ihre Herstellung und Verwendung als Arzneimittel
|
DE102007032347A1
(de)
*
|
2007-07-11 |
2009-01-15 |
Bayer Healthcare Ag |
Aminoacyl-Prodrugs
|
WO2009015000A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Array Biopharma Inc. |
Pyrazole urea derivatives used as kinase inhibitors
|
WO2009053999A2
(en)
*
|
2007-08-07 |
2009-04-30 |
Cadila Healthcare Limited |
Sulfoximine derivatives as factor xa inhibitors
|
TW200908984A
(en)
*
|
2007-08-07 |
2009-03-01 |
Piramal Life Sciences Ltd |
Pyridyl derivatives, their preparation and use
|
US20110118274A1
(en)
*
|
2007-08-23 |
2011-05-19 |
Cornell Research Foundation, Inc. |
Proteasome inhibitors and their use in treating pathogen infection and cancer
|
WO2009036275A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Link Medicine Corporation |
Treatment of neurodegenerative diseases using indatraline analogs
|
US10426750B1
(en)
|
2007-09-18 |
2019-10-01 |
Thermolife International, Llc |
Amino acid supplement formulations
|
US8466187B2
(en)
|
2007-09-18 |
2013-06-18 |
Thermolife International, Llc |
Amino acid compositions
|
US10435356B1
(en)
|
2007-09-18 |
2019-10-08 |
Thermolife International, Llc |
Amino acid compositions
|
US10646508B1
(en)
*
|
2007-09-18 |
2020-05-12 |
Thermolife International, Llc |
Method of safely administering nitrate dietary supplements and compositions
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
FR2924712B1
(fr)
*
|
2007-12-06 |
2012-12-21 |
Univ Maine |
Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
|
EP2070929A1
(de)
|
2007-12-11 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Alkynylarylverbindungen und Salze davon, pharmazeutische Zusammensetzungen damit sowie Verfahren zu ihrer Herstellung und Verwendung
|
AR069650A1
(es)
*
|
2007-12-14 |
2010-02-10 |
Actelion Pharmaceuticals Ltd |
Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
US8372863B2
(en)
*
|
2008-02-25 |
2013-02-12 |
Merck Sharp & Dohme Corp. |
Tetrahydro-1H-pyrrolo fused pyridones
|
JP2011513329A
(ja)
*
|
2008-02-29 |
2011-04-28 |
アレイ バイオファーマ、インコーポレイテッド |
RAF阻害化合物として使用されるイミダゾ[4,5−b]ピリジン誘導体
|
EP2105164B1
(de)
*
|
2008-03-25 |
2011-01-12 |
Affectis Pharmaceuticals AG |
Neuartige P2X7R-Antagonisten und ihre Verwendung
|
US20090246234A1
(en)
*
|
2008-04-01 |
2009-10-01 |
Benjamin Johnson |
Therapeutic Treatment Using Niacin for Skin Disorders
|
PE20140960A1
(es)
|
2008-04-03 |
2014-08-15 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
EP2116539A1
(de)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon
|
US8501734B2
(en)
*
|
2008-05-26 |
2013-08-06 |
Oncotyrol-Center For Personalized Cancer Medicine Gmbh (Ltd.) |
Medical intervention in haematological cancers
|
CN103450241A
(zh)
|
2008-06-17 |
2013-12-18 |
米伦纽姆医药公司 |
硼酸酯化合物及其医药组合物
|
US8524747B2
(en)
*
|
2008-06-25 |
2013-09-03 |
Keio University |
Pharmaceutical compositions
|
KR20200118243A
(ko)
|
2008-08-06 |
2020-10-14 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
WO2010017350A1
(en)
*
|
2008-08-06 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyridine kinase inhibitors
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
WO2010028175A1
(en)
|
2008-09-08 |
2010-03-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
US8513264B2
(en)
*
|
2008-09-10 |
2013-08-20 |
Boehringer Ingelheim International Gmbh |
Combination therapy for the treatment of diabetes and related conditions
|
KR100905419B1
(ko)
*
|
2008-09-11 |
2009-07-02 |
연세대학교 산학협력단 |
세스퀴테르펜 유도체의 용도
|
BRPI0920533A2
(pt)
*
|
2008-10-01 |
2020-12-15 |
Novartis Ag |
Antagonismo de estabilizado para o tratamento de distúrbios relacionados à trilha de porco-espinho
|
US8653143B2
(en)
*
|
2008-10-09 |
2014-02-18 |
Newtree Co., Ltd. |
Use of panduratin derivative or Boesenbergia pandurata extract
|
AR074797A1
(es)
*
|
2008-10-10 |
2011-02-16 |
Japan Tobacco Inc |
Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
EP2349279A4
(de)
*
|
2008-10-28 |
2013-12-25 |
Univ Leland Stanford Junior |
Aldehyddehydrogenase-modulatoren und anwendungsverfahren dafür
|
DE102008059133A1
(de)
*
|
2008-11-26 |
2010-05-27 |
Merck Patent Gmbh |
Difluorphenyl-diacylhydrazid-derivate
|
KR20100060189A
(ko)
*
|
2008-11-27 |
2010-06-07 |
국립암센터 |
에타크리닉 산을 포함하는 트란스글루타미나제 관련 질환 예방 또는 치료용 조성물 및 그를 이용하는 트란스글루타미나제 관련 질환 예방 또는 치료 방법
|
US8362080B2
(en)
*
|
2008-12-18 |
2013-01-29 |
Baylor College Of Medicine |
Increasing glutathione levels for therapy
|
TWI432188B
(zh)
*
|
2008-12-19 |
2014-04-01 |
Merz Pharma Gmbh & Co Kgaa |
供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
|
AU2009331471B2
(en)
|
2008-12-23 |
2015-09-03 |
Boehringer Ingelheim International Gmbh |
Salt forms of organic compound
|
TW201036975A
(en)
|
2009-01-07 |
2010-10-16 |
Boehringer Ingelheim Int |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
|
US9006288B2
(en)
|
2009-01-12 |
2015-04-14 |
Biokier, Inc. |
Composition and method for treatment of diabetes
|
KR20170034928A
(ko)
*
|
2009-01-12 |
2017-03-29 |
바이오키어 인코포레이티드 |
당뇨병 치료 조성물 및 치료방법
|
US9314444B2
(en)
*
|
2009-01-12 |
2016-04-19 |
Biokier, Inc. |
Composition and method for treatment of NASH
|
WO2010081488A1
(en)
*
|
2009-01-15 |
2010-07-22 |
Humanitas Mirasole S.P.A. |
Nitric oxide furoxan derivative compounds endowed with antitumoral activity
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
US20100204329A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Mcfaul William J |
Method of using and establishing an absorption rate level and a neuron firing level
|
US20120046364A1
(en)
*
|
2009-02-10 |
2012-02-23 |
Metabasis Therapeutics, Inc. |
Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
|
ES2345241B1
(es)
*
|
2009-03-16 |
2011-09-08 |
Lipopharma Therapeutics |
Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
|
JP2012521429A
(ja)
*
|
2009-03-23 |
2012-09-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
疼痛治療用のp2x3受容体アンタゴニスト
|
AR076752A1
(es)
*
|
2009-05-07 |
2011-07-06 |
Gruenenthal Chemie |
Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides.
|
US8946204B2
(en)
|
2009-05-07 |
2015-02-03 |
Gruenenthal Gmbh |
Substituted phenylureas and phenylamides as vanilloid receptor ligands
|
JP5808739B2
(ja)
|
2009-05-13 |
2015-11-10 |
サイデックス・ファーマシューティカルズ・インコーポレイテッド |
プラスグレル及びシクロデキストリン誘導体を含む医薬組成物並びにその製造方法及び使用方法
|
EP2440205B1
(de)
*
|
2009-06-12 |
2014-08-27 |
United Therapeutics Corporation |
Iminozucker zur verwendung in der behandlung von bunyaviralen und togaviralen erkrankungen
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
EA201290073A1
(ru)
*
|
2009-08-24 |
2013-01-30 |
Эсэпиен Фармасьютикалз, Инк. |
Соединения мочевины, содержащие 5,6-бициклический гетероарил, как ингибиторы киназ
|
WO2011032320A1
(en)
*
|
2009-09-21 |
2011-03-24 |
F. Hoffmann-La Roche Ag |
Novel alkene oxindole derivatives
|
US20130072427A1
(en)
*
|
2009-09-23 |
2013-03-21 |
Pfizer Inc. |
Gpr 119 modulators
|
CA2812683C
(en)
|
2009-09-25 |
2017-10-10 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
EP2486002B1
(de)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituierte heteroaryl- und arylcyclopropylaminacetamide und ihre verwendung
|
KR20240090632A
(ko)
|
2009-11-27 |
2024-06-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
|
US20130102591A1
(en)
*
|
2010-01-26 |
2013-04-25 |
Andrew Lurie Salzman |
Compositions and methods for prevention and treatment of pulmonary hypertension
|
US8563610B2
(en)
*
|
2010-02-04 |
2013-10-22 |
Rutgers, The State of New Jersey |
Polyunsaturated fatty acids interactions and oxidative stress disorders
|
EP2353591A1
(de)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon
|
JP2013519685A
(ja)
*
|
2010-02-11 |
2013-05-30 |
ヴァンダービルト ユニバーシティー |
mGluR4アロステリック増強剤としてのベンズイソオキサゾール類およびアザベンズイソオキサゾール類、組成物、および神経機能不全を治療する方法
|
PT2534150T
(pt)
|
2010-02-12 |
2017-05-02 |
Chimerix Inc |
Métodos para tratar uma infecção viral
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
AU2011224445B2
(en)
|
2010-03-08 |
2015-08-27 |
Spectrum Pharmaceuticals, Inc. |
Thioxanthone-based autophagy inhibitor therapies to treat cancer
|
MX2012012111A
(es)
*
|
2010-04-19 |
2013-05-30 |
Oryzon Genomics Sa |
Inhibidores de demetilasa-1 especifica de lisina y su uso.
|
US20130231360A1
(en)
*
|
2010-04-22 |
2013-09-05 |
The Brigham And Women S Hospital, Inc. |
Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases
|
US9278135B2
(en)
*
|
2010-04-26 |
2016-03-08 |
Chimerix Inc. |
Methods of treating retroviral infections and related dosage regimes
|
WO2011137046A1
(en)
*
|
2010-04-29 |
2011-11-03 |
Merck Sharp & Dohme Corp. |
Substituted 1,3-benzothiazol-2(3h)-ones and [1,3]thiazolo[5,4-b]pyridin-2(1h)-ones as positive allosteric modulators of mglur2
|
CN102946875A
(zh)
|
2010-05-05 |
2013-02-27 |
贝林格尔.英格海姆国际有限公司 |
组合疗法
|
GB201008005D0
(en)
*
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2011142724A1
(en)
*
|
2010-05-14 |
2011-11-17 |
Agency For Science, Technology And Research |
Novel antimicrobial compounds and uses thereof
|
EP2388005A1
(de)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie
|
ES2623373T3
(es)
|
2010-05-27 |
2017-07-11 |
Catalyst Biosciences, Inc. |
Antagonistas no competitivos del receptor nicotínico
|
GB201010359D0
(en)
*
|
2010-06-21 |
2010-08-04 |
Univ Nottingham |
Compounds for treating proliferative disorders
|
CA2803504C
(en)
|
2010-06-24 |
2022-08-30 |
Boehringer Ingelheim International Gmbh |
A combination for diabetes therapy comprising linagliptin and a long-acting insulin
|
ES2691671T3
(es)
*
|
2010-06-24 |
2018-11-28 |
Alkermes Pharma Ireland Limited |
Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
|
TW201204733A
(en)
*
|
2010-06-25 |
2012-02-01 |
Kowa Co |
Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same
|
US8846671B2
(en)
*
|
2010-07-01 |
2014-09-30 |
Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences |
Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
|
US20130184273A1
(en)
*
|
2010-07-13 |
2013-07-18 |
Bayer Intellectual Property Gmbh |
Bicyclic pyrimidines
|
CN103384670B
(zh)
|
2010-07-28 |
2016-05-25 |
拜耳知识产权有限责任公司 |
取代的咪唑并[1,2-b]哒嗪
|
RU2611437C2
(ru)
|
2010-07-29 |
2017-02-22 |
Оризон Дженомикс С.А. |
Ингибиторы деметилазы lsd1 на основе арилциклопропиламина и их применение в медицине
|
PL2599774T3
(pl)
*
|
2010-07-29 |
2017-01-31 |
Astellas Pharma Inc. |
Skondensowane związki pirydynowe, jako ligandy receptorów kannabinoidowych cb2
|
EP2598480B1
(de)
|
2010-07-29 |
2019-04-24 |
Oryzon Genomics, S.A. |
Cyclopropylaminderivate als lsd1-hemmer
|
EP2415471A1
(de)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie
|
PL392436A1
(pl)
*
|
2010-09-17 |
2012-03-26 |
Adamed Spółka Z Ograniczoną Odpowiedzialnością |
Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
|
US8829026B2
(en)
*
|
2010-10-01 |
2014-09-09 |
Raqualia Pharma Inc. |
Sulfamoyl benzoic acid heterobicyclic derivatives as TRPM8 antagonists
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
SG189882A1
(en)
*
|
2010-10-20 |
2013-06-28 |
Biota Scient Management |
Viral polymerase inhibitors
|
TWI537258B
(zh)
|
2010-11-05 |
2016-06-11 |
百靈佳殷格翰國際股份有限公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
KR101894116B1
(ko)
*
|
2010-11-24 |
2018-08-31 |
메르크 파텐트 게엠베하 |
퀴나졸린 카르복사미드 아제티딘
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
US9096504B2
(en)
*
|
2010-12-01 |
2015-08-04 |
Washington State University |
Controlled chemical release of hydrogen sulfide
|
ES2834986T3
(es)
|
2011-01-07 |
2021-06-21 |
Anji Pharma Us Llc |
Terapias basadas en ligandos de receptores quimiosensoriales
|
US9572784B2
(en)
|
2011-01-07 |
2017-02-21 |
Elcelyx Therapeutics, Inc. |
Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
|
US9211263B2
(en)
|
2012-01-06 |
2015-12-15 |
Elcelyx Therapeutics, Inc. |
Compositions and methods of treating metabolic disorders
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
US11974971B2
(en)
|
2011-01-07 |
2024-05-07 |
Anji Pharmaceuticals Inc. |
Compositions and methods for treating metabolic disorders
|
US11759441B2
(en)
|
2011-01-07 |
2023-09-19 |
Anji Pharmaceuticals Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US9480663B2
(en)
|
2011-01-07 |
2016-11-01 |
Elcelyx Therapeutics, Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
EP2668951B9
(de)
*
|
2011-01-25 |
2017-03-15 |
Viviabiotech, S.L. |
1,2,4-oxadiazolderivate als wirkstoffe zur modulation des glp-1-peptidrezeptors
|
WO2012107498A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
US20120208872A1
(en)
*
|
2011-02-11 |
2012-08-16 |
Taipei Medical University |
Use of tea polyphenols for treating and/or preventing nicotine or nicotine-derived compounds or estrogen induced breast cancer
|
EP3243385B1
(de)
*
|
2011-02-25 |
2021-01-13 |
Merck Sharp & Dohme Corp. |
Neue cyclische azabenzimidazolderivate als antidiabetika
|
US8642655B2
(en)
*
|
2011-03-09 |
2014-02-04 |
Benjamin Johnson |
Systems and methods for preventing cancer and treating skin lesions
|
PL2685827T3
(pl)
|
2011-03-18 |
2016-07-29 |
Corcept Therapeutics Inc |
Pirymidyno-cykloheksylowe modulatory receptora glikokortykoidowego
|
WO2012127466A1
(en)
*
|
2011-03-24 |
2012-09-27 |
Bar Ilan University |
5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
|
WO2012135631A1
(en)
*
|
2011-03-30 |
2012-10-04 |
Arrien Pharmaeuticals Llc |
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
|
WO2012142474A2
(en)
|
2011-04-13 |
2012-10-18 |
Thermolife International, Llc |
N-acetyl beta alanine methods of use
|
JP5901025B2
(ja)
*
|
2011-04-19 |
2016-04-06 |
第一三共株式会社 |
テトラヒドロチアゼピン誘導体
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
EP2524694A1
(de)
*
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes
|
US8487008B2
(en)
*
|
2011-06-22 |
2013-07-16 |
Universita Degli Studi Di Padova |
Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
|
WO2012177263A1
(en)
*
|
2011-06-24 |
2012-12-27 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists
|
US8658677B2
(en)
*
|
2011-07-07 |
2014-02-25 |
Aria Neurosciences Inc. |
Pyridyl-2-methylamino compounds, compositions and uses thereof
|
DK2731947T3
(en)
|
2011-07-15 |
2019-04-23 |
Boehringer Ingelheim Int |
SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
|
UA113291C2
(xx)
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
TW201311679A
(zh)
*
|
2011-08-04 |
2013-03-16 |
Takeda Pharmaceutical |
含氮雜環化合物
|
EP2744775B1
(de)
*
|
2011-08-19 |
2018-03-07 |
Emory University |
Bax-agonist, zusammensetzungen und zugehörige verfahren
|
IN2014CN02646A
(de)
|
2011-09-14 |
2015-08-07 |
Samumed Llc |
|
AR087841A1
(es)
*
|
2011-09-14 |
2014-04-23 |
Chiesi Farma Spa |
Derivados de tetrahidrotriazolopirimidina
|
JP2014531451A
(ja)
|
2011-09-26 |
2014-11-27 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
バニロイド受容体リガンドとしてのアリールまたはn−ヘテロアリール置換メタンスルホンアミド誘導体
|
AU2012314508A1
(en)
*
|
2011-09-26 |
2014-02-27 |
Grunenthal Gmbh |
Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands
|
JP6046154B2
(ja)
|
2011-10-20 |
2016-12-14 |
オリソン ヘノミクス エセ. アー. |
Lsd1阻害剤としての(ヘテロ)アリールシクロプロピルアミン化合物
|
AU2012324803B9
(en)
|
2011-10-20 |
2017-08-24 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
SG11201401856VA
(en)
|
2011-10-26 |
2014-05-29 |
Kempharm Inc |
Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
|
CA2856235A1
(en)
*
|
2011-11-13 |
2013-05-16 |
Blanchette Rockefeller Neurosciences Institute |
Esters of dcpla for the treatment of neurodegenerative disorders
|
EP2782994B1
(de)
|
2011-11-22 |
2017-05-10 |
Trustees Of Tufts College |
Kleinmolekülige verstärker für krebsimpfstoffe mit dendritischen zellen
|
US20140364445A1
(en)
*
|
2011-12-05 |
2014-12-11 |
Glenmark Pharmaceuticals S.A. |
Pharmaceutical composition comprising a trpa1 antagonist and an anticholinergic agent
|
BR112014016808B1
(pt)
|
2012-01-06 |
2022-01-11 |
Anji Pharma (Us) Llc |
Uso de um composto de biguanida para a fabricação de um medicamento para baixar os níveis de glicose no sangue e para o tratamento de um distúrbio do metabolismo de glicose
|
KR102231554B1
(ko)
|
2012-01-06 |
2021-03-23 |
앤지 파마 유에스 엘엘씨 |
대사 장애를 치료하는 조성물 및 방법
|
CN102603493B
(zh)
*
|
2012-01-17 |
2014-03-12 |
青岛农业大学 |
含氟邻烯丙基苯酚类化合物的制备方法及农用生物活性
|
CA2864104A1
(en)
*
|
2012-02-14 |
2013-08-22 |
Repros Therapeutics Inc. |
Selective estrogen receptor modulators with short half-lives and uses thereof
|
CN102614177B
(zh)
*
|
2012-03-06 |
2014-08-06 |
北京伟峰益民科技有限公司 |
卢帕他定在制备治疗慢性阻塞性肺病药物组合物中的应用
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
WO2013144080A1
(en)
*
|
2012-03-30 |
2013-10-03 |
Nestec S.A. |
4-oxo-2-pentenoic acid and cardiovascular health
|
WO2013150529A2
(en)
*
|
2012-04-02 |
2013-10-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Indole, indoline derivatives, compositions comprising them and uses thereof
|
BR112014023670A8
(pt)
*
|
2012-04-04 |
2017-07-25 |
Chiesi Farm Spa |
Composto, composição farmacêutica e suo de um composto
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
US8809376B2
(en)
*
|
2012-04-30 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
EP2849755A1
(de)
|
2012-05-14 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
Xanthinderivat als dpp-4-hemmer zur verwendung bei der behandlung von durch podozyten vermittelten erkrankungen und/oder des nephrotischen syndroms
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
EP2863922A4
(de)
*
|
2012-06-20 |
2015-11-04 |
Univ Vanderbilt |
Substituierte bicyclische alkoxypyrazolanaloga als allosterische modulatoren von mglur5-rezeptoren
|
US20130345205A1
(en)
*
|
2012-06-20 |
2013-12-26 |
Vanderbilt University |
Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors
|
EP2875014B1
(de)
|
2012-07-17 |
2017-11-29 |
Washington University |
Schleimlösungsarzneien und verwendungen dafür
|
CN104780976B
(zh)
|
2012-08-13 |
2019-01-01 |
洛克菲勒大学 |
治疗和诊断黑素瘤
|
WO2014031732A2
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
US20150225369A1
(en)
*
|
2012-08-29 |
2015-08-13 |
Merck Patent Gmbh |
Ddr2 inhibitors for the treatment of osteoarthritis
|
US9278081B2
(en)
*
|
2012-10-04 |
2016-03-08 |
University Of The West Indies |
Extracts from Eucalyptus camaldulensis for the treatment of hyperglycemia and hypertension
|
US8859598B2
(en)
*
|
2012-10-04 |
2014-10-14 |
Allergan, Inc. |
1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
|
WO2014070523A1
(en)
|
2012-11-02 |
2014-05-08 |
Repros Therapeutics Inc. |
Trans-clomiphene for use in cancer therapy
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
EP2922548A4
(de)
*
|
2012-11-21 |
2016-06-01 |
Stategics Inc |
Substituierte triazolo-pyrimidin-verbindungen zur modulation von zellproliferation, -differenzierung und -überleben
|
RU2015121044A
(ru)
*
|
2012-12-05 |
2017-01-12 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Производные фенилэтилпиридина в качестве ингибиторов pde4
|
JP6283862B2
(ja)
|
2012-12-07 |
2018-02-28 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規インダニルオキシジヒドロベンゾフラニル酢酸
|
UY35212A
(es)
|
2012-12-21 |
2014-06-30 |
Gilead Sciences Inc |
Inhibidores de la quinasa que regula la señal de la apoptosis
|
MX370487B
(es)
|
2013-01-08 |
2019-12-16 |
Samumed Llc |
Inhibidores de 3-(benzo-imidazol-2-il)-indazol de la senda de señalización de wnt y usos terapéuticos de los mismos.
|
CU20130027A7
(es)
*
|
2013-02-28 |
2014-10-30 |
Ct De Neurociencias De Cuba |
Chaperoninas químicas como nuevos moduladores moleculares de la beta agregación proteica presente en las enfermedades conformacionales
|
WO2014153214A1
(en)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Arginine methyl transferase inhibtors and uses thereof
|
US9045455B2
(en)
|
2013-03-14 |
2015-06-02 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
US9447079B2
(en)
|
2013-03-14 |
2016-09-20 |
Epizyme, Inc. |
PRMT1 inhibitors and uses thereof
|
US9120757B2
(en)
|
2013-03-14 |
2015-09-01 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
EP2970124B1
(de)
|
2013-03-14 |
2019-05-22 |
The Board of Trustees of the Leland Stanford Junior University |
Mitochondriale aldehyd-dehydrogenase-2-modulatoren und verfahren zur verwendung davon
|
JP2016514164A
(ja)
|
2013-03-14 |
2016-05-19 |
エピザイム,インコーポレイティド |
アルギニンメチルトランスフェラーゼ阻害剤としてのピラゾール誘導体およびその使用
|
US9394258B2
(en)
*
|
2013-03-14 |
2016-07-19 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
SI2970132T1
(sl)
|
2013-03-14 |
2021-02-26 |
Epizyme, Inc. |
Inhibitorji argininmetiltransferaze in njihove uporabe
|
WO2014144659A1
(en)
|
2013-03-14 |
2014-09-18 |
Epizyme, Inc. |
Pyrazole derivatives as prmt1 inhibitors and uses thereof
|
HUE036925T2
(hu)
|
2013-03-15 |
2018-08-28 |
Janssen Pharmaceutica Nv |
C-fms kináz inhibitorként használható helyettesített piridin származékok
|
US20140335079A1
(en)
*
|
2013-05-07 |
2014-11-13 |
Emory University |
Solenopsin and derivatives, therapeutic compositions, and methods related thereto
|
JP5740062B1
(ja)
*
|
2013-07-03 |
2015-06-24 |
三菱化学フーズ株式会社 |
毛状疣贅病の予防および/または治療方法
|
TN2016000022A1
(en)
*
|
2013-07-18 |
2017-07-05 |
Novartis Ag |
Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
|
US20150045435A1
(en)
*
|
2013-08-06 |
2015-02-12 |
Indiana University Research And Technology Corporation |
Compounds and methods for treating diabetes
|
EP3035921A1
(de)
*
|
2013-08-20 |
2016-06-29 |
Bristol-Myers Squibb Company |
Imidazopyridazin-kinasehemmer zur behandlung einer aak1-vermittelten krankheit oder störung wie morbus alzheimer, bipolaren störungen, schmerzen und schizophrenie
|
WO2015027160A2
(en)
*
|
2013-08-22 |
2015-02-26 |
Northeastern University |
Allosteric modulators of the cannibinoid 1 receptor
|
BR112016005509B1
(pt)
|
2013-09-13 |
2021-01-19 |
The Board Of Trustees Of The University Of Arkansas |
uso de uma composição
|
EP3052190A4
(de)
*
|
2013-10-01 |
2017-07-19 |
New York University |
Amino-, amido- und heterocyclische verbindungen als modulatoren der wutaktivität und verwendungen davon
|
EP3060257B1
(de)
|
2013-10-22 |
2021-02-24 |
Translate Bio, Inc. |
Lipidzusammensetzungen zur verabreichung von mrna
|
TWI634120B
(zh)
*
|
2013-12-13 |
2018-09-01 |
日商第一三共股份有限公司 |
5-羥基-4-(三氟甲基)吡唑并吡啶衍生物及其用途
|
TN2016000228A1
(en)
|
2013-12-17 |
2017-10-06 |
Esteve Labor Dr |
SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS.
|
US9381171B2
(en)
*
|
2013-12-19 |
2016-07-05 |
Samsung Electronics Co., Ltd. |
Composition including dapsone for preventing or treating side effect of steroid in subject and use of the composition
|
US9862704B2
(en)
*
|
2013-12-20 |
2018-01-09 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases
|
CN104744446B
(zh)
*
|
2013-12-30 |
2019-06-25 |
广东东阳光药业有限公司 |
杂芳化合物及其在药物中的应用
|
CA2939120A1
(en)
|
2014-01-10 |
2015-07-16 |
Rgenix, Inc. |
Lxr agonists and uses thereof
|
US9636298B2
(en)
|
2014-01-17 |
2017-05-02 |
Methylgene Inc. |
Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
|
DK3107902T3
(da)
|
2014-02-20 |
2021-05-03 |
Cornell Univ Cornell Center For Technology Enterprise & Commercialization Cctec |
Forbindelser og fremgangsmåder til at hæmme fascin
|
US10231965B2
(en)
|
2014-02-20 |
2019-03-19 |
Ignyta, Inc. |
Molecules for administration to ROS1 mutant cancer cells
|
JP6615109B2
(ja)
|
2014-02-28 |
2019-12-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Dpp−4阻害薬の医学的使用
|
US9771360B2
(en)
|
2014-03-21 |
2017-09-26 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use
|
UY36132A
(es)
|
2014-05-20 |
2015-11-30 |
Millennium Pharm Inc |
Métodos para terapia de cáncer
|
US10300042B2
(en)
|
2014-06-23 |
2019-05-28 |
Celgene Corporation |
Apremilast for the treatment of a liver disease or a liver function abnormality
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
WO2016062277A1
(zh)
*
|
2014-10-24 |
2016-04-28 |
朗齐生物医学股份有限公司 |
驱虫药用于制备抗癌医药组合物中的应用
|
US10213445B2
(en)
*
|
2014-11-06 |
2019-02-26 |
ARIZONA BOARD OF REGENTS on behalf of THE UNIVERSITY OF ARIZONA, A BODY CORPORATE |
Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer
|
US9603820B2
(en)
*
|
2014-11-07 |
2017-03-28 |
Northwestern University |
Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma
|
CA2969540C
(en)
|
2014-12-02 |
2023-03-21 |
Ignyta, Inc. |
Combinations for the treatment of neuroblastoma
|
CA2969268A1
(en)
|
2014-12-02 |
2016-06-09 |
Bayer Pharma Aktiengesellschaft |
Heteroaryl-substituted imidazo[1,2-a]pyridines and their use
|
JP6462877B2
(ja)
*
|
2014-12-02 |
2019-01-30 |
ケムファーム・インコーポレーテッド |
オキシモルホンの安息香酸、安息香酸誘導体及びヘテロアリールカルボン酸結合体、プロドラッグ、その製造法及び使用
|
WO2016090174A1
(en)
*
|
2014-12-03 |
2016-06-09 |
Auckland Uniservices, Ltd. |
Kinase inhibitor prodrug for the treatment of cancer
|
US10278976B2
(en)
*
|
2014-12-12 |
2019-05-07 |
Mira Dx, Inc. |
Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumors
|
JP6951976B2
(ja)
*
|
2015-01-22 |
2021-10-20 |
マイトコン ファーマシューティカルズ, インコーポレイテッド |
神経筋疾患、神経変性疾患、自己免疫疾患、発達疾患および/または代謝疾患の処置のための、脳由来神経栄養因子(bdnf)の誘導された発現
|
CA3213864A1
(en)
|
2015-03-04 |
2016-09-09 |
Vanda Pharmaceuticals Inc. |
Dosing regimen of tradipitant
|
WO2016154362A1
(en)
|
2015-03-23 |
2016-09-29 |
The Brigham And Women's Hospital, Inc. |
Tolerogenic nanoparticles for treating diabetes mellitus
|
EA201792304A1
(ru)
|
2015-04-20 |
2018-03-30 |
Эпизайм, Инк. |
Комбинированная терапия для лечения рака
|
WO2016176420A1
(en)
*
|
2015-04-30 |
2016-11-03 |
Musc Foundation For Research Development |
Oxindole compounds and pharmaceutical compositions thereof
|
US20160324914A1
(en)
|
2015-05-05 |
2016-11-10 |
Tocol Pharmaceuticals, Llc |
Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation
|
TWI713534B
(zh)
|
2015-06-11 |
2020-12-21 |
日商第一三共股份有限公司 |
5-羥基-4-(三氟甲基)吡唑并吡啶衍生物之結晶及其用途
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
WO2017024004A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023984A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024015A1
(en)
*
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US9675608B2
(en)
*
|
2015-08-26 |
2017-06-13 |
Macau University Of Science And Technology |
Identification of natural small-molecules AMPK activators for treatment of cancers or multidrug-resistant cancers
|
KR102698411B1
(ko)
*
|
2015-10-08 |
2024-08-26 |
쑤저우 운씨엔 이야오 커지 요씨엔 공시 |
Wnt 신호 전달 경로 억제제 및 이의 치료적 적용
|
GB201519450D0
(en)
*
|
2015-11-03 |
2015-12-16 |
Univ Liverpool |
Novel treatment
|
WO2017079759A1
(en)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof
|
US9549907B1
(en)
*
|
2015-11-13 |
2017-01-24 |
Sovereign Pharmaceuticals, Llc |
Immediate release oral guaifenesin solution
|
US10765665B2
(en)
*
|
2015-11-24 |
2020-09-08 |
Melin Jeffrey |
Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases
|
US10508106B2
(en)
*
|
2015-11-25 |
2019-12-17 |
Convergene Llc |
Bicyclic BET bromodomain inhibitors and uses thereof
|
BR112018012255A2
(pt)
|
2015-12-18 |
2018-12-04 |
Ignyta Inc |
método para tratar câncer
|
US10494360B2
(en)
*
|
2016-03-09 |
2019-12-03 |
Netherlands Translational Research Center B.V |
Inhibitors of indoleamine 2,3-dioxygenase
|
EP3430004B1
(de)
*
|
2016-03-14 |
2020-07-15 |
Pliva Hrvatska D.O.O. |
Feste formen von nilotinibsalzen
|
US10064834B2
(en)
*
|
2016-05-09 |
2018-09-04 |
Texas Tech University System |
Carbidopa for the treatment of cancer
|
WO2017197036A1
(en)
*
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
CN108289865B
(zh)
*
|
2016-05-26 |
2021-02-23 |
中国热带农业科学院热带生物技术研究所 |
诺卡酮的应用
|
HRP20221446T1
(hr)
|
2016-06-01 |
2023-01-06 |
Biosplice Therapeutics, Inc. |
Postupci za pripremu n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida
|
EP3251668A1
(de)
|
2016-06-02 |
2017-12-06 |
Pharmotech SA |
Cannabidiolzusammensetzungen und verwendungen davon
|
WO2017211979A1
(en)
|
2016-06-10 |
2017-12-14 |
Boehringer Ingelheim International Gmbh |
Combinations of linagliptin and metformin
|
WO2018049019A1
(en)
|
2016-09-07 |
2018-03-15 |
Temple University - Of The Commonwealth System Of Higher Education |
Compositions and methods for treatment of insulin resistance
|
EP3446704A1
(de)
|
2017-08-24 |
2019-02-27 |
Isofol Medical AB |
[6r]-mthf eine effiziente folatalternative in 5-fluoruracilbasierter chemotherapie
|
EP3446703A1
(de)
*
|
2017-08-24 |
2019-02-27 |
Isofol Medical AB |
6r]-mthf-mehrfachbolusverabreichung in 5-fluoruracil-basierter chemotherapie
|
BR112019008061A2
(pt)
|
2016-10-21 |
2019-09-17 |
Samumed Llc |
métodos de uso de indazol-3-carboxamidas e seu uso como inibidores da via de sinalização de wnt/b-catenina
|
JP2019533702A
(ja)
|
2016-11-07 |
2019-11-21 |
サミュメッド リミテッド ライアビリティ カンパニー |
単回用量の調整済み注射用製剤
|
JP2020500199A
(ja)
|
2016-11-21 |
2020-01-09 |
バイキング・セラピューティクス・インコーポレイテッド |
グリコーゲン蓄積症の治療方法
|
EP3554263B1
(de)
*
|
2016-12-15 |
2023-07-19 |
Société des Produits Nestlé S.A. |
Zusammensetzungen und verfahren zur modulierung der verdaulichkeit bei einem haustier
|
US10723716B2
(en)
|
2016-12-21 |
2020-07-28 |
New York University |
Alpha-helix mimetics as modulators of Abeta self-assembly
|
EP3573953A1
(de)
|
2017-01-26 |
2019-12-04 |
Boehringer Ingelheim International GmbH |
Benzyloxypyridylcyclopropancarbonsäuren, pharmazeutische zusammensetzungen und verwendungen davon
|
US10793530B2
(en)
|
2017-01-26 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
US10919859B2
(en)
|
2017-01-26 |
2021-02-16 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
JP7050792B2
(ja)
|
2017-01-26 |
2022-04-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベンジルオキシピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用
|
CN110300755B
(zh)
|
2017-02-08 |
2022-10-04 |
勃林格殷格翰国际有限公司 |
茚满基氨基氮杂二氢苯并呋喃乙酸、用于治疗糖尿病的药物组合物
|
BR112019016668A2
(pt)
|
2017-02-14 |
2020-04-07 |
Isofol Medical Ab |
métodos para aumentar a concentração de plasma de durd e para inibir timidilato-sintase (ts) em um indivíduo humano.
|
US10517842B2
(en)
*
|
2017-03-15 |
2019-12-31 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Methods of modulating miRNA levels and compositions for use in the same
|
RU2675496C1
(ru)
*
|
2017-03-31 |
2018-12-20 |
Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук |
Способ получения алкиловых эфиров гидроксибензойных кислот
|
EP3600282A4
(de)
|
2017-03-31 |
2020-08-19 |
Corcept Therapeutics, Inc. |
Glucocorticoid-rezeptor-modulatoren zur behandlung von gebärmutterhalskrebs
|
US20180280319A1
(en)
*
|
2017-04-04 |
2018-10-04 |
University Of The Sciences |
Compounds and compositions for treatment of breast cancer
|
FR3066393B1
(fr)
*
|
2017-05-16 |
2019-07-19 |
Polyneuros |
Principe actif constitue par un melange de composes poly-lysine et utilisation dans la prevention des avc et le traitement de la phase inflammatoire post-avc
|
US11491150B2
(en)
|
2017-05-22 |
2022-11-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
EP3634426A4
(de)
|
2017-06-05 |
2021-04-07 |
Viking Therapeutics, Inc. |
Zusammensetzungen zur behandlung von fibrose
|
IL271759B2
(en)
*
|
2017-07-19 |
2024-01-01 |
Ignyta Inc |
Pharmaceutical preparations that include anthraxtinib
|
US10639313B2
(en)
*
|
2017-09-01 |
2020-05-05 |
Ndsu Research Foundation |
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
|
CN111093671A
(zh)
|
2017-09-13 |
2020-05-01 |
万达制药公司 |
以托吡坦对特应性皮炎的改进治疗
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
WO2019071144A1
(en)
|
2017-10-05 |
2019-04-11 |
Fulcrum Therapeutics, Inc. |
USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION
|
WO2019077506A1
(en)
|
2017-10-17 |
2019-04-25 |
Ignyta, Inc. |
PHARMACEUTICAL COMPOSITIONS AND SOLID GALENIC FORMS
|
US11607458B2
(en)
*
|
2017-10-25 |
2023-03-21 |
Georgia State University Research Foundation, Inc. |
Enrichment-triggered chemical delivery system
|
SG11202002947TA
(en)
|
2017-11-03 |
2020-04-29 |
Aclaris Therapeutics Inc |
Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same
|
AU2018373028A1
(en)
|
2017-11-21 |
2020-04-30 |
Inspirna, Inc. |
Polymorphs and uses thereof
|
US11787828B2
(en)
|
2018-03-22 |
2023-10-17 |
Viking Therapeutics, Inc. |
Crystalline forms and methods of producing crystalline forms of a compound
|
WO2019191032A1
(en)
|
2018-03-26 |
2019-10-03 |
Clear Creek Bio, Inc. |
Compositions and methods for inhibiting dihydroorotate dehydrogenase
|
EP3802499B1
(de)
|
2018-06-04 |
2024-04-10 |
Corcept Therapeutics Incorporated |
Pyrimidin-cyclohexenyl-glucocorticoid-rezeptor-modulatoren
|
KR20210044822A
(ko)
|
2018-08-10 |
2021-04-23 |
어클라리스 쎄라퓨틱스, 인코포레이티드 |
피롤로피리미딘 itk 억제제
|
EP4360713A3
(de)
|
2018-09-18 |
2024-05-22 |
F. Hoffmann-La Roche AG |
Chinazolinderivate als antitumormittel
|
US11389432B2
(en)
|
2018-12-19 |
2022-07-19 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
US11234971B2
(en)
|
2018-12-19 |
2022-02-01 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
KR102657097B1
(ko)
|
2018-12-19 |
2024-04-15 |
코어셉트 쎄라퓨틱스 인코포레이티드 |
헤테로아릴-케톤 융합 아자데칼린 화합물인 렐라코릴란트를 함유하는 약학적 제제
|
BR112021021477A2
(pt)
|
2019-05-02 |
2021-12-21 |
Aclaris Therapeutics Inc |
Composto, composição farmacêutica e método para tratar uma doença mediada por jak em um indivíduo necessitando do mesmo
|
EP4072556A4
(de)
|
2019-12-11 |
2024-01-03 |
Corcept Therapeutics Incorporated |
Verfahren zur behandlung von antipsychotikainduzierter gewichtszunahme mit miricorilant
|
CN114728875A
(zh)
|
2019-12-13 |
2022-07-08 |
因思博纳公司 |
金属盐及其用途
|
US20210315880A1
(en)
|
2020-03-20 |
2021-10-14 |
Clear Creek Bio, Inc. |
Methods of treating viral infections using inhibitors of nucleotide synthesis pathways
|
CA3182272A1
(en)
|
2020-05-06 |
2021-11-11 |
Corcept Therapeutics Incorporated |
Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators
|
US11071739B1
(en)
|
2020-09-29 |
2021-07-27 |
Genus Lifesciences Inc. |
Oral liquid compositions including chlorpromazine
|
US11865139B2
(en)
|
2020-11-12 |
2024-01-09 |
Thermolife International, Llc |
Method of treating migraines and headaches
|
KR20230124020A
(ko)
|
2020-12-21 |
2023-08-24 |
코어셉트 쎄라퓨틱스 인코포레이티드 |
피리미딘 시클로헥실 글루코코르티코이드 수용체 조절제의제조 방법
|
CN113354558B
(zh)
*
|
2021-07-12 |
2022-03-11 |
无锡双启科技有限公司 |
一种2-氨基-5-氟苯腈的制备方法
|